Sandra Navarra
- EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
2023/10/12 by Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen +55 · 43 citations
Medicine · #Abatacept #Azathioprine #B-cell activating factor #Belimumab #Disease #Efalizumab #Hydroxychloroquine #Idiopathic pulmonary fibrosis #Immunology #Infliximab #Intensive care medicine #Internal medicine #Lupus nephritis #Maintenance therapy #Medicine #Nintedanib #Prednisone #Rheumatoid Arthritis Research and Therapies #Rituximab #Systemic Lupus Erythematosus Research #Systemic Sclerosis and Related Diseases #Systemic lupus erythematosus
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
2011/02/01 by Sandra Navarra, Sandra V Navarra, Renato Guzmán +27 · 2 citations
Medicine · Neuroscience · #Adverse effect #Alternative medicine #Antibody #Autoimmune disease #B cell #B-cell activating factor #Belimumab #Clinical endpoint #Clinical trial #Connective tissue disease #Disease #Immunology #Internal medicine #Lupus erythematosus #Medicine #Multiple Sclerosis Research Studies #Pathology #Placebo #Randomized controlled trial #Systemic Lupus Erythematosus Research #Systemic lupus erythematosus #Vagus Nerve Stimulation Research